Preview

Russian competition law and economy

Advanced search
Open Access Open Access  Restricted Access Subscription Access

General Summary of the Session “Pharmaceutical Market Development: Access and Affordability” Within the 4th Eurasian Economic Forum Eurasian Economic Commission June 26, 2025

EDN: QHTASC

Abstract

The general summary provides a brief overview of the session “Development of the pharmaceutical market: access and affordability” held within the 4th Eurasian Economic Forum in Minsk on June 26, 2025. The discussion was based on the results of the study of the pharmaceutical sector of the EAEU conducted by the Department of Antitrust Regulation of the EEC. The sector requires constant monitoring and support measures from national and Eurasian regulators, taking into account increased requirements for the conditions of production and circulation of medicines, limited budgetary resources for the purchase of medicines, other rapidly changing factors, production technologies, growing demands of the medical community and consumers. The result of the session was a comprehensive assessment of the state of competition in the pharmaceutical sector of the EAEU.

About the Authors

Vladimir S. Kovale
Eurasian Economic Commission; MGIMO-University; Financial University under the Government of the Russian Federation
Russian Federation

 Smolensky Boulevard, 3/5, bldg 1, Moscow, 119121 



Sergey V. Maksimov
Eurasian Economic Commission, Institute of Economics of the Russian Academy of Sciences
Russian Federation

 Smolensky Boulevard, 3/5, bldg 1, Moscow, 119121 



Review

For citations:


Kovale V.S., Maksimov S.V. General Summary of the Session “Pharmaceutical Market Development: Access and Affordability” Within the 4th Eurasian Economic Forum Eurasian Economic Commission June 26, 2025. Russian competition law and economy. 2025;(3):96-102. (In Russ.) EDN: QHTASC

Views: 4


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2542-0259 (Print)